The CSMB wins Research Canada’s Organization Leadership in Advocacy Award

Press release by Research Canada
OTTAWA, June 9, 2021 – Research Canada is pleased to announce the 2021 Individual and Organization Leadership in Advocacy Awardees: Dr. Aubie Angel, the founding and current President of Friends of CIHR (FCIHR), a professor at the University of Manitoba and President and Board Chair of the Diabetes Research and Treatment Centre, and the Canadian Society for Molecular Biosciences, a professional association of active researchers and students in the fields of biochemistry, cell biology, molecular biology and genetics.

The Research Canada Leadership in Advocacy Award recognizes outstanding champions of health research and health innovation. Recognition of Canadian health research—the kind that attracts the necessary public and political support—often comes from the dedicated and tireless efforts of health research advocates who educate policymakers, the media and the public about the social and economic benefits of health research and its promise of future cures and, importantly, a better quality of life for all Canadians. This year’s winners exemplify this. + + +

Postdoctoral Fellow Position – University of Manitoba

POSITION OVERVIEW:

University of ManitobaThe postdoctoral fellow will work in a multidisciplinary team investigating epigenetic processes in normal and cancer cell states. The projects investigate the genomic landscape of histone modifications and chromatin modifying enzymes (protein arginine methyltransferases 1/5, DOTL1) in active and repressed states. The project will be done jointly with the Lakowski Lab in the Faculty of Pharmacy, University of Manitoba. This position will initially be for 1 year, and based on performance, be expended for several more years.

QUALIFICATIONS AND EDUCATION REQUIREMENTS

  • PhD in Biochemistry, Molecular Biology or related field.
  • Strong background in epigenomic research with expertise in the chromatin immunoprecipitation (ChIP) assay and ChIP-Seq.
  • Experience with gene editing (CRISPR-Cas9), chromatin accessibility assays and HiC assays are a plus.

DEPARTMENT DESCRIPTION

The Department of Biochemistry and Medical Genetics is located on the Bannatyne Campus, the main medical and health sciences campus of the University of Manitoba. The department is home to biochemistry, molecular biological sciences, and medical genetics expertise, practiced in an intellectually enriching research and teaching environment in the Max Rady College of Medicine and Faculty of Graduate Studies.

The Davie lab explores the role of chromatin modifiers in regulating gene expression. His research group has a long-term interest in the chromatin structure/function, epigenetic regulation, nuclear matrix, nuclear organization, chromatin modifying enzymes including histone deacetylases, kinases, methyltransferases, and histone modifications.

HOW TO APPLY? Interested applicants should send their applications as one single .pdf file to Dr Jim Davie (Jim.davie@umanitoba.ca), with the following information:

  • The subject of the email should be “Postdoc EpigenBMG”
  • Two-page CV
  • Publication List
  • One page Research Summary

 ABOUT THE CITY

Manitoba encompasses prairie, boreal plains, boreal shield, taiga shield, Hudson plains, and southern arctic ecozones offering a wide range of research as well as recreational opportunities. The city of Winnipeg is located at the confluence of three rivers: Seine, the Red River, and Assiniboine. Its population is diverse, reflecting multiple waves of immigration. Its urban forest is a noteworthy treasure. Distinctive historical buildings bear witness to the city’s prominence during the Wheat Boom of the late 19th and early 20th centuries, but today the city and provincial economies are diverse. Winnipeg is vibrant and affordable. It boasts a lively arts scene, including a major symphony orchestra, the Royal Winnipeg Ballet and Qaumajuq – the Inuit Art Centre at the Winnipeg Art Gallery.

View a PDF version of this advertisement